Home > Nanotechnology Columns > Bergeson & Campbell, P.C. > SCCS Guidance on Safety Assessment of Nanomaterials in Cosmetics Published in Regulatory Toxicology and Pharmacology
 |
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
The European Commission's Scientific Committee on Consumer Safety (SCCS) announced on March 3, 2020, that the April 2020 issue of Regulatory Toxicology and Pharmacology includes "The SCCS guidance on the safety assessment of nanomaterials in cosmetics."
March 11th, 2020
SCCS Guidance on Safety Assessment of Nanomaterials in Cosmetics Published in Regulatory Toxicology and Pharmacology
The European Commission's Scientific Committee on Consumer Safety (SCCS) announced on March 3, 2020, that the April 2020 issue of Regulatory Toxicology and Pharmacology includes "The SCCS guidance on the safety assessment of nanomaterials in cosmetics." See https://www.sciencedirect.com/science/article/abs/pii/S0273230020300374 The highlights state that:
- The guidance provides an overview of the key issues and data requirements relating to the safety assessment of nanomaterials;
- The guidance facilitates the applicants and the risk assessors in preparing and assessing safety dossiers on nanomaterials; and
- The guidance is complementary to the SCCS general Notes of Guidance.
The article is available for purchase through the Regulatory Toxicology and Pharmacology website.
As reported in our November 5, 2019, blog item, SCCS published an updated Guidance on the Safety Assessment of Nanomaterials in Cosmetics. See https://nanotech.lawbc.com/2019/11/ec-committee-publishes-guidance-on-safety-assessment-of-nanomaterials-in-cosmetics/ and https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_233.pdf The Guidance updates SCCS's 2012 Guidance (SCCS/1484/12) on the safety assessment of nanomaterials in cosmetic products. It covers the main elements of safety assessment -- general considerations (Section 2), material characterization (Section 3), exposure assessment (Section 4), hazard identification and dose-response characterization (Section 5), and risk assessment (Section 6).
Bookmark:
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||